Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Commodore Capital LP reported a 9.90% stake in Karyopharm Therapeutics Inc. (Schedule 13G)

Event Mar 26, 2026 · Filed Apr 2, 2026

Commodore Capital LP reported a 9.90% stake in Karyopharm Therapeutics Inc., 1,950,000 shares, as a passive investor on Mar 26, 2026. Filed Apr 2, 2026 (Schedule 13G).

Stake
9.90%
Shares
1,950,000
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP9.90%1,950,000
Commodore Capital Master LP9.90%1,950,000
Robert Egen Atkinson9.90%1,950,000
Michael Kramarz9.90%1,950,000

Source

View original at SEC

Related